Eisai, UCL commence phase I clinical studies for anti-tau monoclonal antibody
Eisai and UCL will conduct joint research in Alzheimer's disease for novel anti-tau antibody E2814
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.